Office of New Drugs Custom Medical Queries (OCMQs) for Safety Signal Detection in Clinical Trial Dat

Office of New Drugs Custom Medical Queries (OCMQs) for Safety Signal Detection in Clinical Trial Data - 06/23/2026

The goal of this webinar is to provide general audiences information on the development and use of Office of New Drugs (OND) Custom Medical Queries (OCMQs) during premarket safety evaluation. OCMQs are standardized groupings of adverse event terms designed to help identify potential safety issues during review of clinical trial adverse event data a

http://www.fda.gov/drugs/news-events-human-drugs/office-new-drugs-custom-medical-queries-ocmqs-safety-signal-detection-clinical-trial-data-06232026 fda.gov

RSS Hunter • Yesterday